⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9623477 | 0.65 | — | — | |
| SCHEMBL3821147 | 0.64 | — | — | |
| SCHEMBL287637 | 0.61 | — | — | |
| SCHEMBL8816870 | 0.54 | — | — | |
| SCHEMBL9394395 | 0.53 | — | — | |
| SCHEMBL5143109 | 0.52 | — | — | |
| SCHEMBL2168489 | 0.52 | — | — | |
| SCHEMBL22288289 | 0.52 | — | — | |
| SCHEMBL9065371 | 0.51 | — | — | |
| SCHEMBL15863069 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7125879-B2 | HIV inhibiting pyrimidines derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-10-24 | — | — | US | disclosed |
| US-20040198739-A1 | Prevention reproduction of virus | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-10-07 | — | — | US | disclosed |